<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20130617013691N11</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2020-01-21</date_registration>
      <primary_sponsor>Tabriz University of Medical Sciences</primary_sponsor>
      <public_title>Effect of Multisensory Stimulation care plan on pain of Retinopathy</public_title>
      <acronym></acronym>
      <scientific_title>Effect of Multisensory Stimulation care plan on pain of Infants during Eye Examination for Retinopathy</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2019-11-21</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>50</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/43447</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Single, Purpose: Supportive, Randomization description: Using a checklist prepared using Randlist software, the first group will be assigned to the control group by drawing one of the letters a or b and the other letter by the intervention group. A and B are divided and placed in opaque envelopes by the research assistant (allocation concealment). Parents are asked to select one of the envelopes.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Condition 1: Retinopathy. Condition 2: Pain.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group:One hour before eye examination, 0.5% tetracaine drops will be given 3 times each time for 5 minutes.Then, 5 minutes before the examination, during the insertion of the speculum, and 5 minutes after the speculum is removed, the pain score and the physiological data of the infant will be recorded.After recording basic data,The researcher's help will try to keep one standard, small, short, full-length, one- six month-old baby pacifier in the infants mouth.(The same type pacifier will be used for all infants).This will continue during the examination.After removing the speculum from the eye which means that the examination is completed,The pacifier will come out of the baby's mouth.Simultaneously, foot massage will be performed slowly by the researcher 2 minutes before the eye examination.After removal of the spaculum, the foot massage will be discontinued immediately.One minute before inserting the spaculum, distracting through the sound of a toy,Shaken by the mother done.At the end of the examination, the rattle will also be muted. Intervention 2: Control group: One hour before eye examination, 0.5% tetracaine drops will be given 3 times each time for 5 minutes.Then, 5 minutes before the examination, during the insertion of the speculum, and 5 minutes after the speculum is removed, the pain score and the physiological data of the infant will be recorded.There is no intervention during the examination.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Only part of the data, such as information about the main outcome, can be shared.

When:
Start of access period 6 months after printing results

To whom:
Researchers at academic and research institutes can apply for data if needed.

Conditions:
Use of this research data in similar research is permitted unless noted and copied.

Where to obtain:
Applicants can apply for documentation or data through the following
Send message to email: saba.moghtader73@gmail.com
Send message to email: Arshadi_m@yahoo.com
Call the phone number: 09141392603

How to obtain:
Seven days after receipt of the request the applicant will be provided with the documentation or data file.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mohamad Arshadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Seyedoshohada Hospital, 17 Shahrivar Blvd, Urmia City</address>
        <city>Tabriz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5718748983</zip>
        <telephone>+98 44 3346 2362</telephone>
        <email>saba.moghtader73@gmail.com</email>
        <affiliation>Tabriz University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Mohamad Arshadi Bostanabad</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Nursing, South Shariati St., Tabriz, Iran</address>
        <city>Tabriz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5718748983</zip>
        <telephone>+98 41 3479 6770</telephone>
        <email>Arshadi_m@yahoo.com</email>
        <affiliation>Tabriz University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Infants with retinopathy 2-6 months old
The infant is calm and awake
Do not take painkillers or sadatives for the past 24 hours
Mother of the baby to be present
Parents of infants consent to participate in the study</inclusion_criteria>
      <agemin>2 months</agemin>
      <agemax>6 months</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Do not attempt to insert the spaculum more than once
There is no need for urgent resuscitation during the examination
History of CPR, operation, Intraventricular hemorrage more than grade 2, Major infant birth defect such az cadiac and CNS disaeses
Oral problems such as cleft palate and oral ulsers
No abnormality in the leg area</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>H36</hc_code>
      <hc_code>R52</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Retinal disorders in diseases classified elsewhere</hc_keyword>
      <hc_keyword>Pain, unspecified</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>N/A</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group:One hour before eye examination, 0.5% tetracaine drops will be given 3 times each time for 5 minutes.Then, 5 minutes before the examination, during the insertion of the speculum, and 5 minutes after the speculum is removed, the pain score and the physiological data of the infant will be recorded.After recording basic data,The researcher's help will try to keep one standard, small, short, full-length, one- six month-old baby pacifier in the infants mouth.(The same type pacifier will be used for all infants).This will continue during the examination.After removing the speculum from the eye which means that the examination is completed,The pacifier will come out of the baby's mouth.Simultaneously, foot massage will be performed slowly by the researcher 2 minutes before the eye examination.After removal of the spaculum, the foot massage will be discontinued immediately.One minute before inserting the spaculum, distracting through the sound of a toy,Shaken by the mother done.At the end of the examination, the rattle will also be muted.</i_keyword>
      <i_keyword>Control group: One hour before eye examination, 0.5% tetracaine drops will be given 3 times each time for 5 minutes.Then, 5 minutes before the examination, during the insertion of the speculum, and 5 minutes after the speculum is removed, the pain score and the physiological data of the infant will be recorded.There is no intervention during the examination.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Pain score in Neonatal Infant Pain Scale. Timepoint: Five minutes before an eye examination/During the eye examination/Five minutes after doing eye examination. Method of measurement: Neonatal Infant Pain Scale.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tabriz University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2019-10-27</approval_date>
        <contact_name>Ethics committee of Tabriz University of Medical Sciences</contact_name>
        <contact_address>seyed o Shohada Hospital, 17 Shahrivar Blvd, urmia city Tabriz East Azarbaijan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
